Measurement of antiplatelet inhibition during neurointerventional procedures: The effect of antithrombotic duration and loading dose: Neurointerventional reports

Journal of Neuroimaging

Volumn 20, Issue 1, 2010, Pages 64-69

  Pandya, D J ^a   Fitzsimmons, B F M ^a   Wolfe, T J ^a   Hussain, S I ^a   Lynch, J R ^a   Ortega Gutierrez, S ^a   Zaidat, O O ^a  

^a FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

Author keywords

Accumetric; Aneurysm coiling; Carotid stenting; Intracranial stenting; Neurointervention; PFA 100; Platelet function; Stroke; Testing

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; PURINERGIC P2Y12 RECEPTOR; TICLOPIDINE;

ANGIOGRAPHY; ANTICOAGULATION; ARTICLE; ARTIFICIAL EMBOLISM; FEMALE; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PREMEDICATION; STENT; THROMBOCYTE; THROMBOCYTE FUNCTION; ANALOGS AND DERIVATIVES; BRAIN DISEASES; COHORT ANALYSIS; DOSE RESPONSE; DRUG EFFECTS; PROSPECTIVE STUDY; TIME;

ASPIRIN; BLOOD PLATELETS; BRAIN DISEASES; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; STENTS; TICLOPIDINE; TIME FACTORS;

EID: 74049140381     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2008.00322.x     Document Type: Article

References (13)

1. Almaleh MD, Morre S, Campbell CL. Clopidogrel resistance? Bus Briefing: US Cardiol 2006 : 1 4.
2. Smith SC Jr., Feldman TE, Hirshfeld JW Jr., et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2006 113 : e166 e286.
3. Nguyen TA, Diodati JG, Pharand C. Resistance to clopidogrel: a review of evidence. J Am Coll Cardiol 2005 45 : 1157 1164.
4. Michos ED, Ardehali R, Blumenthal RS, et al. Aspirin and clopidogrel resistance. Mayo Clin Proc 2006 81 (4 518 526.
5. Prabhakaran S, Wells KR, Lee VH, et al. Prevalence and risk factors for aspirin and clopidogrel resistance in cerebrovascular stenting. AJNR 2008 29 : 1 5.
6. Schroeder WS, Ghobrial L, Gandhi PJ. Possible mechanisms of drug-induced aspirin and clopidogrel resistance. J Thromb Thrombolysis 2006 22 : 139 150.
7. Violi F, Pignatelli P. Aspirin resistance: is this term meaningful? Curr Opin Hematol 2006 13 : 331 336.
8. Fitzgerald DJ, Maree A. Aspirin and clopidogrel resistance. Hematology 2007 1 : 114 120.
9. Perneby C, Wallén NH, Rooney C, et al. Dose- and time-dependent antiplatelet effects of aspirin. Thromb Haemost 2006 95 (4 652-658.
10. Gurbel PA, Bliden KP, Hiatt BL, et al. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003 107 (23 2908 2913.
11. Järemo P, Lindahl TL, Fransson SG, et al. Individual variations of platelet inhibition after loading doses of clopidogrel. J Intern Med 2002 252 (3 233 238.
12. Lau WC, Waskell LA, Watkins PB, et al. Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction. Circulation 2003 107 (1 32 37.
13. Accumetric Website Patient Information http://www.accumetrics.com/news/ details.asp?ID=39.